Gilead Sciences has 19 disclosed EU lobbying meetings from 2024-10-01 to 2026-05-08: 5 with the European Commission and 14 with Members of the European Parliament. Source: EU Transparency Register no. 258845020786-10, Commission disclosures and MEP declarations. Methodology
Gilead Sciences
EU lobbying footprint — who they meet, and on what.
- Register no.
- 258845020786-10 ↗
- Disclosed meetings
- 19 (5 Commission · 14 MEP)
- Period
- 2024-10-01 → 2026-05-08
Declared fields of interest: Budget · Business and industry · Competition · Public health · Research and innovation · Trade
Lobbying profile
as declared 2026-03-02- Category
- Companies & groups
- Legal status
- Corporation
- Declared lobbying cost
- €1,000,000
- Lobbying FTEs
- 2.2
At a glance
- Health2
- Ulla Schwager1
- Boriša Falatar1
- Cecile Billaux1
- Michael McGrath1
- Vincenzo Matano1
Disclosed meetings
Newest first. EC = European Commission, EP = Member of the European Parliament.
- Biotech Actsource ↗
- Biotechsource ↗
- 2025-12-03ECUlla Schwager · Head of UnitExchange of views on developments in the pharmaceutical industry and aspects of competition law and policy enforcement in this industry sectorsource ↗
- 2025-09-04ECBoriša Falatar · Cabinet of Commissioner Hadja LahbibHIV preventionsource ↗
- Review of the EU General Pharmaceutical Legislationsource ↗
- 2025-07-01ECCecile Billaux · Head of UnitGilead’s long-acting HIV prevention drug: LENACAPAVIR – access in Africasource ↗
- 2025-06-20ECMichael McGrath · Cabinet of Commissioner Michael McGrathExchange of views on issues relating to competitiveness and corporate sustainabilitysource ↗
- Cancer treatments and HIV vaccinessource ↗
- 2025-03-27ECVincenzo Matano · Cabinet of Executive Vice-President Raffaele FittoGeneral Exchange on the Company’s Activitiessource ↗
- Introductory meetingsource ↗
- Politique de santé de l Union européennesource ↗
- Europe de la Santésource ↗
- Meeting on HIV policiessource ↗
- HIV vaccinationsource ↗
- HIVsource ↗
- Health policysource ↗
- Introductory Meetingsource ↗
- Prevention of infectious diseasessource ↗
- HIVsource ↗
Lobbying in these areas
Frequently asked
How many EU lobbying meetings has Gilead Sciences disclosed?
Gilead Sciences (EU Transparency Register no. 258845020786-10) appears in 19 disclosed meetings with EU officials and MEPs between 2024-10-01 and 2026-05-08: 5 with the European Commission and 14 with Members of the European Parliament.
What does Gilead Sciences lobby on?
Gilead Sciences's disclosed EU meetings most often concern Health. Every meeting and its topic is listed with its official source on this page.
Who does Gilead Sciences meet in Brussels?
Across its disclosed meetings, Gilead Sciences has met Commission officials including Ulla Schwager, Boriša Falatar, Cecile Billaux, and MEPs including GONZÁLEZ CASARES Nicolás, MONTSERRAT Dolors, BOSSE Stine. These are counts of officially disclosed meetings, not a measure of influence.
Primary sources
- EU Transparency Register profile (no. 258845020786-10) ↗
- European Commission meeting disclosures ↗
- European Parliament — MEP meeting declarations ↗
Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.
Get the EU lobbying brief
We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.